- As it grows, Medicare Advantage is enrolling more low-income and medically complex beneficiaries: recent trends in beneficiary clinical characteristics, health care utilization, and spending1
- Assessing COVID-19-related symptoms in outpatient adult and adolescent subjects in clinical trials of drugs and biological products for COVID-19 prevention or treatment1
- Assessing user fees under the Biosimilar User Fee Amendments of 20171
- Assessing user fees under the prescription drug user fee amendments of 20171
- Basic safety and essential performance of medical electrical equipment, medical electrical systems, and laboratory medical equipment: standards specific information for the Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program : guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff1
- Bed check: inpatient psychiatric care in three California counties1
- Benefits and services1
- Best practices in developing proprietary names for human prescription drug products1
- Better health, greater social cohesion linked to voter participation1
- Beyond the case count: the wide-ranging disparities of COVID-19 in the United States1
- Billions in estimated Medicare Advantage payments from diagnoses reported only on health risk assessments raise concerns1
- Biocompatibility testing of medical devices: standards specific information for the Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program : guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff1
- Biological product deviation reporting for blood and plasma establishments1
- Bipartisan Rx for America's health care: a practical path to reform1
- Bipartisan approaches to tackling health care costs at the state level1
- Black Lung Benefits Program: oversight is needed to address trust fund solvency strained by bankruptcies : testimony before the Committee on Education and Labor, Subcommittee on Workforce Protections, House of Representatives1
- Blood glucose monitoring test systems for prescription point-of-care use: guidance for industry and Food and Drug Administration staff1
- Bone anchors: premarket notification (510(k)) submissions : guidance for industry and Food and Drug Administration staff1
- Breast implants: certain labeling recommendations to improve patient communication : guidance for industry and Food and Drug Administration staff1
- Bringing free lunch to all of New York City’s school children1